デフォルト表紙
市場調査レポート
商品コード
1548180

がん組織診断の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Cancer Tissue Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032


出版日
ページ情報
英文 170 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
がん組織診断の世界市場調査レポート:産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年08月01日
発行: Value Market Research
ページ情報: 英文 170 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん組織診断市場の世界需要は、2023年の192億8,000万米ドルから2032年には298億8,000万米ドル近くの市場規模に達すると推定され、調査期間2024-2032年のCAGRは4.99%です。

がん組織診断では、組織サンプルを分析してがん細胞を同定し、その特徴を明らかにすることで、がんの診断、予後、治療計画を支援します。このプロセスには、病理組織学、免疫組織化学、分子診断学などの様々な技術が含まれます。しばしば生検によって得られる組織サンプルを検査し、がんの存在、種類、病期を検出します。これらの診断検査は、臨床医ががんの遺伝的・分子的プロファイルを理解するのに役立ち、個別化された治療アプローチを可能にします。診断技術の進歩と標的療法の開発により、がん診断の精度と有効性が向上し、がん管理において重要な役割を果たしています。

市場力学

がん組織診断市場は、世界のがん罹患率の上昇と、早期かつ正確な診断の重視の高まりに後押しされています。次世代シーケンシングやデジタルパソロジーのような技術の進歩は、がん診断における精度と効率の向上をもたらし、大きな市場機会を生み出しています。個別化医療と標的療法への注目の高まりにより、詳細な分子・遺伝子プロファイリングが必要となり、診断技術の革新が促進されています。さらに、新興市場におけるがん検診プログラムの普及とヘルスケアインフラの拡大が、がん組織診断市場の成長に寄与しています。診断プロセスにおける人工知能と機械学習の統合は、能力と効率をさらに高め、新たなビジネスチャンスをもたらしています。しかし、高コストと複雑な規制要件ががん組織診断市場の成長を抑制する可能性があります。

調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、がん組織診断薬の世界市場における各セグメントを包括的に評価することもできます。がん組織診断薬業界の成長と動向は、この調査に全体的なアプローチを提供します。

市場セグメンテーション

がん組織診断薬市場レポートのこのセクションでは、国・地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家がそれぞれの製品またはサービスのターゲット層を特定する上で、今後の機会を支援します。

製品別

  • インサイチュハイブリダイゼーション(ISH)検査キット(蛍光インサイチュハイブリダイゼーション(FISH)キット、発色インサイチュハイブリダイゼーション(CISH)キット)
  • 分子診断検査キット(ポリメラーゼ連鎖反応(PCR)キット、次世代シーケンシング(NGS)キット)
  • コンパニオン診断検査キット(遺伝子検査キット、バイオマーカー検査キット)
  • 免疫組織化学(IHC)検査キット

がん別

  • 乳がん
  • 肺がん
  • 大腸がん
  • 前立腺がん
  • 卵巣がん
  • 血液がん
  • 肝臓がん
  • 膵臓がん
  • 皮膚がん(黒色腫)
  • その他

エンドユーザー別

  • 病院
  • 専門センター
  • 長期ケアセンター
  • 診断センター
  • 学術・研究機関

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東&アフリカにおけるがん組織診断薬市場の現在および将来の需要を強調する地域展望をカバーしています。さらに、本レポートは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 がん組織診断-産業分析

  • イントロダクション:市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 がん組織診断薬の世界市場分析:製品別

  • 製品別概要
  • 製品別の過去および予測データ分析
  • インサイチュハイブリダイゼーション(ISH)検査キット(蛍光インサイチュハイブリダイゼーション(FISH)キット、発色インサイチュハイブリダイゼーション(CISH)キット)
  • 分子診断検査キット(ポリメラーゼ連鎖反応(PCR)キット、次世代シーケンシング(NGS)キット)
  • コンパニオン診断検査キット(遺伝子検査キット、バイオマーカー検査キット)
  • 免疫組織化学(IHC)検査キット

第6章 がん組織診断の世界市場分析:がん別

  • がん別の概要
  • 過去および予測データ分析:がん別
  • 乳がん
  • 肺がん
  • 大腸がん
  • 前立腺がん
  • 卵巣がん
  • 血液がん
  • 肝臓がん
  • 膵臓がん
  • 皮膚がん(黒色腫)
  • その他

第7章 がん組織診断の世界市場分析:エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去および予測データ分析
  • 病院
  • 専門センター
  • 長期ケアセンター
  • 診断センター
  • 学術・研究機関

第8章 がん組織診断の世界市場分析:地域別

  • 地域別展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米:セグメント別
    • 北米国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州セグメント別
    • 欧州国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋セグメント別
    • アジア太平洋国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカセグメント別
    • ラテンアメリカ国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカセグメント別
    • 中東・アフリカ国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 がん組織診断薬企業の競合情勢

  • がん組織診断薬市場の競合
  • パートナーシップ/提携/合意
  • 合併・買収
  • 新製品の上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Abcam Plc
  • Danaher Corporation
  • Merck KGaA
  • Cancer Genetics Inc.
  • Agilent Technologies Inc.
  • Enzo Life Sciences Inc
  • Abbott
  • Bio Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Exact Science
  • Biocartis NV
  • Bio SB
  • Quidel Corporation
  • Amoy Diagnostics CO. Ltd.
  • F. Hoffmann-La Roche Ltd
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • In Situ Hybridization (ISH) Test Kits (Fluorescent In Situ Hybridization (FISH) Kits, Chromogenic In Situ Hybridization (CISH) Kits) Market Sales By Geography (USD MN)
  • Molecular Diagnostics Test Kits (Polymerase Chain Reaction (PCR) Kits, Next-Generation Sequencing (NGS) Kits) Market Sales By Geography (USD MN)
  • Companion Diagnostics Test Kits (Genetic Testing Kits, Biomarker Testing Kits) Market Sales By Geography (USD MN)
  • Immunohistochemistry (IHC) Test Kits Market Sales By Geography (USD MN)
  • Analysis By Cancer (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Lung Cancer Market Sales By Geography (USD MN)
  • Colorectal Cancer Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Ovarian Cancer Market Sales By Geography (USD MN)
  • Hematologic Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Pancreatic Cancer Market Sales By Geography (USD MN)
  • Skin Cancer (Melanoma) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-user (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Centers Market Sales By Geography (USD MN)
  • Long-term Care Centers Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Cancer Tissue Diagnostics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Cancer Tissue Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Cancer Tissue Diagnostics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Cancer
  • Market Attractiveness Analysis By End-user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • In Situ Hybridization (ISH) Test Kits (Fluorescent In Situ Hybridization (FISH) Kits, Chromogenic In Situ Hybridization (CISH) Kits) Market Sales By Geography (USD MN)
  • Molecular Diagnostics Test Kits (Polymerase Chain Reaction (PCR) Kits, Next-Generation Sequencing (NGS) Kits) Market Sales By Geography (USD MN)
  • Companion Diagnostics Test Kits (Genetic Testing Kits, Biomarker Testing Kits) Market Sales By Geography (USD MN)
  • Immunohistochemistry (IHC) Test Kits Market Sales By Geography (USD MN)
  • Global Market Analysis By Cancer (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Lung Cancer Market Sales By Geography (USD MN)
  • Colorectal Cancer Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Ovarian Cancer Market Sales By Geography (USD MN)
  • Hematologic Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Pancreatic Cancer Market Sales By Geography (USD MN)
  • Skin Cancer (Melanoma) Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-user (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Specialty Centers Market Sales By Geography (USD MN)
  • Long-term Care Centers Market Sales By Geography (USD MN)
  • Diagnostic Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112115540

The global demand for Cancer Tissue Diagnostics Market is presumed to reach the market size of nearly USD 29.88 Billion by 2032 from USD 19.28 Billion in 2023 with a CAGR of 4.99% under the study period 2024-2032.

Cancer tissue diagnostics involves analyzing tissue samples to identify cancerous cells and determine their characteristics, which aids in cancer diagnosis, prognosis, and treatment planning. This process includes various techniques such as histopathology, immunohistochemistry, and molecular diagnostics. Tissue samples, often obtained through biopsy, are examined to detect cancer presence, type, and stage. These diagnostic tests help clinicians understand the genetic and molecular profile of the cancer, allowing for personalized treatment approaches. Advances in diagnostic technologies and the development of targeted therapies have enhanced the accuracy and effectiveness of cancer diagnostics, playing a crucial role in cancer management.

MARKET DYNAMICS

The cancer tissue diagnostics market is propelled by the increasing incidence of cancer globally, combined with a growing emphasis on early & accurate diagnosis. Technological advancements, such as next-generation sequencing & digital pathology, offer improved accuracy and efficiency in cancer diagnostics, creating significant market opportunities. The rising focus on personalized medicine & targeted therapies necessitates detailed molecular and genetic profiling, driving innovation in diagnostic technologies. Additionally, the growing adoption of cancer screening programs and expanding healthcare infrastructure in emerging markets contribute to the growth of the cancer tissue diagnostics market. The integration of artificial intelligence & machine learning in diagnostic processes further enhances capabilities and efficiency, presenting additional opportunities. However, high costs and complex regulatory requirements may restrain cancer tissue diagnostics market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cancer Tissue Diagnostics. The growth and trends of Cancer Tissue Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cancer Tissue Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • In Situ Hybridization (ISH) Test Kits (Fluorescent In Situ Hybridization (FISH) Kits, Chromogenic In Situ Hybridization (CISH) Kits)
  • Molecular Diagnostics Test Kits (Polymerase Chain Reaction (PCR) Kits, Next-Generation Sequencing (NGS) Kits)
  • Companion Diagnostics Test Kits (Genetic Testing Kits, Biomarker Testing Kits)
  • Immunohistochemistry (IHC) Test Kits

By Cancer

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Hematologic Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Skin Cancer (Melanoma)
  • Others

By End-user

  • Hospitals
  • Specialty Centers
  • Long-term Care Centers
  • Diagnostic Centers
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cancer Tissue Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cancer Tissue Diagnostics market include Abcam Plc, Danaher Corporation, Merck KGaA, Cancer Genetics Inc., Agilent Technologies Inc., Enzo Life Sciences Inc, Abbott, Bio Rad Laboratories Inc., Thermo Fisher Scientific Inc., Exact Science, Biocartis NV, Bio SB, Quidel Corporation, Amoy Diagnostics CO. Ltd., F. Hoffmann-La Roche Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CANCER TISSUE DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Cancer
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER TISSUE DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. In Situ Hybridization (ISH) Test Kits (Fluorescent In Situ Hybridization (FISH) Kits, Chromogenic In Situ Hybridization (CISH) Kits) Historic and Forecast Sales By Regions
  • 5.4. Molecular Diagnostics Test Kits (Polymerase Chain Reaction (PCR) Kits, Next-Generation Sequencing (NGS) Kits) Historic and Forecast Sales By Regions
  • 5.5. Companion Diagnostics Test Kits (Genetic Testing Kits, Biomarker Testing Kits) Historic and Forecast Sales By Regions
  • 5.6. Immunohistochemistry (IHC) Test Kits Historic and Forecast Sales By Regions

6. GLOBAL CANCER TISSUE DIAGNOSTICS MARKET ANALYSIS BY CANCER

  • 6.1. Overview By Cancer
  • 6.2. Historical and Forecast Data Analysis By Cancer
  • 6.3. Breast Cancer Historic and Forecast Sales By Regions
  • 6.4. Lung Cancer Historic and Forecast Sales By Regions
  • 6.5. Colorectal Cancer Historic and Forecast Sales By Regions
  • 6.6. Prostate Cancer Historic and Forecast Sales By Regions
  • 6.7. Ovarian Cancer Historic and Forecast Sales By Regions
  • 6.8. Hematologic Cancer Historic and Forecast Sales By Regions
  • 6.9. Liver Cancer Historic and Forecast Sales By Regions
  • 6.10. Pancreatic Cancer Historic and Forecast Sales By Regions
  • 6.11. Skin Cancer (Melanoma) Historic and Forecast Sales By Regions
  • 6.12. Others Historic and Forecast Sales By Regions

7. GLOBAL CANCER TISSUE DIAGNOSTICS MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-user
  • 7.2. Historical and Forecast Data Analysis By End-user
  • 7.3. Hospitals Historic and Forecast Sales By Regions
  • 7.4. Specialty Centers Historic and Forecast Sales By Regions
  • 7.5. Long-term Care Centers Historic and Forecast Sales By Regions
  • 7.6. Diagnostic Centers Historic and Forecast Sales By Regions
  • 7.7. Academic & Research Institutes Historic and Forecast Sales By Regions

8. GLOBAL CANCER TISSUE DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER TISSUE DIAGNOSTICS COMPANIES

  • 9.1. Cancer Tissue Diagnostics Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF CANCER TISSUE DIAGNOSTICS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abcam Plc
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Danaher Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Merck KGaA
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Cancer Genetics Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. Agilent Technologies Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Enzo Life Sciences Inc
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. Abbott
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Bio Rad Laboratories Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. Thermo Fisher Scientific Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Exact Science
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. Biocartis NV
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Bio SB
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Quidel Corporation
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments
  • 10.16. Amoy Diagnostics CO. Ltd.
    • 10.16.1 Company Overview
    • 10.16.2 Company Revenue
    • 10.16.3 Products
    • 10.16.4 Recent Developments
  • 10.17. F. Hoffmann-La Roche Ltd
    • 10.17.1 Company Overview
    • 10.17.2 Company Revenue
    • 10.17.3 Products
    • 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies